Health Canada is looking for your participation in their consultation on priority review pathways and health care systems needed in Canada. Please see below:
Health Canada invites you to participate in this online consultation by completing a short questionnaire. Health Canada is actively seeking feedback from all interested and affected parties to inform the development of accelerated drug review pathways for those medications that best address health care system needs.
How to participate
Please click here to complete the questionnaire. Participation is voluntary. All responses will remain anonymous and kept confidential. The results will be summarized by Health Canada in aggregate form only.
Should you encounter technical difficulty with the questionnaire, you may send a written submission by email to [email protected].
In addition to this online consultation, Health Canada will continue to meet with provincial and territorial governments and work with Indigenous partners, as well as hold dedicated discussions with stakeholders, to promote an understanding of the proposal and seek further input.
The deadline to provide written comments and responses to the questionnaire is April 20, 2018.